BioNTech SE
F:22UA
BioNTech SE
F:22UA
Price:
76.4
EUR
-2.55%
Market Cap:
€18.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BioNTech SE
F:22UA
|
DE |
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
M
|
Minth Group Ltd
F:M3I
|
CN |
|
Francotyp Postalia Holding AG
F:FPH
|
DE |
|
S
|
Sprouts Farmers Market Inc
XMUN:1FA
|
US |
|
Sequana Medical NV
XBRU:SEQUA
|
BE |
|
G
|
Grupo Simec SAB de CV
AMEX:SIM
|
MX |
|
John Wiley & Sons Inc
F:2F7
|
US |
|
I
|
iQIYI Inc
F:IQ8
|
CN |
|
M
|
Mercer International Inc
F:AEZ
|
CA |
|
P
|
Paychex Inc
F:PCX
|
US |
Wall St Price Targets
22UA Price Targets Summary
BioNTech SE
BioNTech SE
Wall Street analysts forecast 22UA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 22UA is 117 EUR with a low forecast of 72.25 EUR and a high forecast of 165.58 EUR.
Lowest Forecast
Price Target
72.25
EUR
5% Downside
Average Forecast
Price Target
117
EUR
53% Upside
Highest Forecast
Price Target
165.58
EUR
117% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 22UA's stock price target?
Price Target
117
EUR
117
EUR
According to Wall Street analysts, the average 1-year price target for 22UA is 117 EUR with a low forecast of 72.25 EUR and a high forecast of 165.58 EUR.
What is the Revenue forecast for BioNTech SE?
Projected CAGR
8%
8%
Over the last 7 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 8 years is 8%.
